PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 1, 20260 citations

Transdermal Delivery of Lornoxicam via Transethosomal Gel as a Novel Strategy for Management of Rheumatoid Arthritis.

View Full Paper
AMAyesha MuneerSSShefaat Ullah ShahRMRashna Mirza

Key Points

  • This research aims to explore a new gel formulation for effective transdermal delivery of lornoxicam in managing rheumatoid arthritis.
  • Development of LOR-TES gel for transdermal application
  • Evaluation of drug delivery efficiency and skin permeation
  • Assessment of sustained release properties
  • LOR-TES gel shows enhanced transdermal drug delivery compared to conventional methods
  • The formulation provides sustained release of lornoxicam
  • Improved skin permeation leads to better management of rheumatoid arthritis symptoms.

Abstract

The developed LOR-TES gel enhanced transdermal drug delivery, offering sustained release and improved permeation. It presents a promising strategy for effective management of rheumatoid arthritis through the transdermal route.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Muneer et al. (2026) studied this question.

synapsesocial.com/papers/69a3d8e7ec16d51705d302a1https://doi.org/10.1080/03639045.2026.2637594
Ask AI
Helpful
Bookmark
Share
View Full Paper